Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1

Chan, Paul; Lee, Nelson; Zaman, Mukhtiar; Adisasmito, Wiku; Coker, Richard; Hanshaoworakul, Wanna; Gasimov, Viktor; Oner, Ahmet; DOĞAN, Nazim; Tsang, Owen; Phommasack, Bounlay; Touch, Sok; Bamgboye, Ebun; Swenson, Anna; Toovey, Stephen; Dreyer, Nancy

doi:10.1093/infdis/jis509

Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1

Chan P. K. S., Lee N., Zaman M., Adisasmito W., Coker R., Hanshaoworakul W., ...Daha Fazla

JOURNAL OF INFECTIOUS DISEASES, cilt.206, sa.9, ss.1359-1366, 2012 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 206 Sayı: 9
Basım Tarihi: 2012
Doi Numarası: 10.1093/infdis/jis509
Dergi Adı: JOURNAL OF INFECTIOUS DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1359-1366
Atatürk Üniversitesi Adresli: Evet

Özet

Background. Oseltamivir is widely used as treatment for influenza virus A subtype H5N1 (hereafter, "H5N1") infection but, like any intervention, is not always effective.